Chronic Pain Consumption Epilepsy White Paper 
MGC Pharma
FEBRUARY 15, 2018
Not only would Australia get a large piece of the $55 billion global market thanks to international exports, but Medicinal Cannabis would be accessible to tens of thousands of chronic pain sufferers throughout Australia. kg of THC per annum for Epilepsy, MS and HIV/Aids sufferers alone. kg of CBD and 163.7
Cannabis Law Report
OCTOBER 17, 2019
This white paper offers a primer to the complex and confusing global cannabis industry as it stands today. But the global legal landscape is confusing and constantly evolving, making it essential for people and businesses around the world to secure strong legal representation. This is true even if the CBD comes from industrial hemp.
Expert insights. Personalized for you.
100 
Let's personalize your content